The mechanisms responsible for the increase in ceftazidime MIC in two Escherichia coli in vitro selected mutants, Caz/20-1 and Caz/20-2, were studied. OmpF loss and overexpression of acrB, acrD and acrF that were associated with acrR and marR mutations and sdiA overexpression, together with mutations A233T and I332V in FtSI (PBP3) resulted in ceftazidime resistance in Caz/20-2, multiplying by 128-fold the ceftazidime MIC in the parental clinical isolate PS/20. Absence of detectable β-lactamase hydrolytic activity in the crude extract of Caz/20-2 was observed, and coincided with Q191K and P209S mutations in AmpC and a nucleotide substitution at −28 in the ampC promoter, whereas β-lactamase hydrolytic activity in crude extracts of PS/20 and Caz/20-1 strains was detected. Nevertheless, a fourfold increase in ceftazidime MIC in Caz/20-1 compared with that in PS/20 was due to the increased transcript level of acrB derived from acrR mutation. The two Caz mutants and PS/20 showed the same mutations in AmpG and ParE.
AhmedA. M., ShimamotoT.2008; Emergence of a cefepime- and cefpirome-resistant Citrobacter freundii clinical isolate harbouring a novel chromosomally encoded AmpC beta-lactamase, CMY-37. Int J Antimicrob Agents 32:256–261 [View Article][PubMed]
AlekshunM. N., LevyS. B., MealyT. R., SeatonB. A., HeadJ. F.2001; The crystal structure of MarR, a regulator of multiple antibiotic resistance, at 2.3 A resolution. Nat Struct Biol 8:710–714 [View Article][PubMed]
AonoR., TsukagoshiN., YamamotoM.1998; Involvement of outer membrane protein TolC, a possible member of the mar-sox regulon, in maintenance and improvement of organic solvent tolerance of Escherichia coli K-12. J Bacteriol 180:938–944[PubMed]
AsakoH., NakajimaH., KobayashiK., KobayashiM., AonoR.1997; Organic solvent tolerance and antibiotic resistance increased by overexpression of marA in Escherichia coli.. Appl Environ Microbiol 63:1428–1433[PubMed]
BarbosaA. R., GiufrèM., CerquettiM., Bajanca-LavadoM. P.2011; Polymorphism in ftsI gene and β-lactam susceptibility in Portuguese Haemophilus influenzae strains: clonal dissemination of β-lactamase-positive isolates with decreased susceptibility to amoxicillin/clavulanic acid. J Antimicrob Chemother 66:788–796 [View Article][PubMed]
BettsM. J., RussellR.2003; Amino acid properties and consequences of substitutions. In Bioinformatics for Geneticists pp. 289–316 Edited by BarnesM. R., GrayI. C. Chichester: John Wiley & Sons, Ltd; [View Article]
CaroffN., EspazeE., GautreauD., RichetH., ReynaudA.2000; Analysis of the effects of -42 and -32 ampC promoter mutations in clinical isolates of Escherichia coli hyperproducing ampC. J Antimicrob Chemother 45:783–788 [View Article][PubMed]
CLSI2006Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically Approved Standard M7–A7, 7th edn Wayne, PA: Clinical and Laboratory Standards Institute;
CorvecS., CaroffN., EspazeE., MarraillacJ., DrugeonH., ReynaudA.2003; Comparison of two RT-PCR methods for quantifying ampC specific transcripts in Escherichia coli strains. FEMS Microbiol Lett 228:187–191 [View Article][PubMed]
CurtisN. A. C., OrrD., RossG. W., BoultonM. G.1979; Competition of β-lactam antibiotics for the penicillin-binding proteins of Pseudomonas aeruginosa, Enterobacter cloacae, Klebsiella aerogenes, Proteus rettgeri, and Escherichia coli: comparison with antibacterial activity and effects upon bacterial morphology. Antimicrob Agents Chemother 16:325–328 [View Article][PubMed]
DubusA., LedentP., Lamotte-BrasseurJ., FrèreJ. M.1996; The roles of residues Tyr150, Glu272, and His314 in class C β-lactamases. Proteins 25:473–485[PubMed]
EberhardtC., KuerschnerL., WeissD. S.2003; Probing the catalytic activity of a cell division-specific transpeptidase in vivo with β-lactams. J Bacteriol 185:3726–3734 [View Article][PubMed]
Fernández-CuencaF., PascualA., Martínez-MartínezL.2005; Hyperproduction of AmpC β-lactamase in a clinical isolate of Escherichia coli associated with a 30 bp deletion in the attenuator region of ampC.. J Antimicrob Chemother 56:251–252 [View Article][PubMed]
GriffithK. L., ShahI. M., WolfR. E.Jr2004; Proteolytic degradation of Escherichia coli transcription activators SoxS and MarA as the mechanism for reversing the induction of the superoxide (SoxRS) and multiple antibiotic resistance (Mar) regulons. Mol Microbiol 51:1801–1816 [View Article][PubMed]
KeckW., GlaunerB., SchwarzU., Broome-SmithJ. K., SprattB. G.1985; Sequences of the active-site peptides of three of the high-Mr penicillin-binding proteins of Escherichia coli K-12. Proc Natl Acad Sci U S A 82:1999–2003 [View Article][PubMed]
KernW. V., OethingerM., Jellen-RitterA. S., LevyS. B.2000; Non-target gene mutations in the development of fluoroquinolone resistance in Escherichia coli.. Antimicrob Agents Chemother 44:814–820 [View Article][PubMed]
KobayashiK., TsukagoshiN., AonoR.2001; Suppression of hypersensitivity of Escherichia coli acrB mutant to organic solvents by integrational activation of the acrEF operon with the IS1 or IS2 element. J Bacteriol 183:2646–2653 [View Article][PubMed]
LeeA., MaoW., WarrenM. S., MistryA., HoshinoK., OkumuraR., IshidaH., LomovskayaO.2000; Interplay between efflux pumps may provide either additive or multiplicative effects on drug resistance. J Bacteriol 182:3142–3150 [View Article][PubMed]
LindeH. J., NotkaF., MetzM., KochanowskiB., HeisigP., LehnN.2000; In vivo increase in resistance to ciprofloxacin in Escherichia coli associated with deletion of the C-terminal part of MarR. Antimicrob Agents Chemother 44:1865–1868 [View Article][PubMed]
MaejimaT., InoueM., MitsuhashiS.1991; In vitro antibacterial activity of KP-736, a new cephem antibiotic. Antimicrob Agents Chemother 35:104–110 [View Article][PubMed]
Martínez-MartínezL., ConejoM. C., PascualA., Hernández-AllésS., Ramírez de Arellano-RamosE., BenedíJ., PereaJ.2000; Activities of imipenem and cephalosporins against clonally related strains of Escherichia coli hyperproducing chromosomal β-lactamase and showing altered porin profiles. Antimicrob Agents Chemother 44:2534–2536 [View Article][PubMed]
Nguyen-DistècheM., FraipontC., BuddelmeijerN., NanningaN.1998; The structure and function of Escherichia coli penicillin-binding protein 3. Cell Mol Life Sci 54:309–316 [View Article][PubMed]
NicoloffH., PerretenV., McMurryL. M., LevyS. B.2006; Role for tandem duplication and lon protease in AcrAB-TolC- dependent multiple antibiotic resistance (Mar) in an Escherichia coli mutant without mutations in marRAB or acrRAB.. J Bacteriol 188:4413–4423 [View Article][PubMed]
OteoJ., NavarroC., CercenadoE., Delgado-IribarrenA., WilhelmiI., OrdenB., GarcíaC., MiguelañezS., Pérez-VázquezM.& other authors (2006; Spread of Escherichia coli strains with high-level cefotaxime and ceftazidime resistance between the community, long-term care facilities, and hospital institutions. J Clin Microbiol 44:2359–2366 [View Article][PubMed]
ParkJ. T., RaychaudhuriD., LiH., NormarkS., Mengin-LecreulxD.1998; MppA, a periplasmic binding protein essential for import of the bacterial cell wall peptide L-alanyl-γ-D-glutamyl-meso-diaminopimelate. J Bacteriol 180:1215–1223[PubMed]
Pérez-CapillaT., BaqueroM. R., Gómez-GómezJ. M., IonelA., MartínS., BlázquezJ.2005; SOS-independent induction of dinB transcription by beta-lactam-mediated inhibition of cell wall synthesis in Escherichia coli. J Bacteriol 187:1515–1518 [View Article][PubMed]
PietteA., FraipontC., Den BlaauwenT., AarsmanM. E. G., PastoretS., Nguyen-DistècheM.2004; Structural determinants required to target penicillin-binding protein 3 to the septum of Escherichia coli.. J Bacteriol 186:6110–6117 [View Article][PubMed]
PomposielloP. J., BennikM. H. J., DempleB.2001; Genome-wide transcriptional profiling of the Escherichia coli responses to superoxide stress and sodium salicylate. J Bacteriol 183:3890–3902 [View Article][PubMed]
QueenanA. M., ShangW., KaniaM., PageM. G. P., BushK.2007; Interactions of ceftobiprole with β-lactamases from molecular classes A to D. Antimicrob Agents Chemother 51:3089–3095 [View Article][PubMed]
RuizJ., CasellasS., Jiménez de AntaM. T., VilaJ.1997; The region of the parE gene, homologous to the quinolone-resistant determining region of the gyrB gene, is not linked with the acquisition of quinolone resistance in Escherichia coli clinical isolates. J Antimicrob Chemother 39:839–840 [View Article][PubMed]
Sánchez-CéspedesJ., VilaJ.2007; Partial characterisation of the acrAB locus in two Citrobacter freundii clinical isolates. Int J Antimicrob Agents 30:259–263 [View Article][PubMed]
SongW., BaeI. K., LeeY.-N., LeeC. H., LeeS. H., JeongS. H.2007; Detection of extended-spectrum beta-lactamases by using boronic acid as an AmpC beta-lactamase inhibitor in clinical isolates of Klebsiella spp. and Escherichia coli. J Clin Microbiol 45:1180–1184 [View Article][PubMed]
TavíoM. M., AquiliV. D., PovedaJ. B., AntunesN. T., Sánchez-CéspedesJ., VilaJ.2010; Quorum-sensing regulator sdiA and marA overexpression is involved in in vitro-selected multidrug resistance of Escherichia coli.. J Antimicrob Chemother 65:1178–1186 [View Article][PubMed]
TraczD. M., BoydD. A., BrydenL., HizonR., GierckeS., Van CaeseeleP., MulveyM. R.2005; Increase in ampC promoter strength due to mutations and deletion of the attenuator in a clinical isolate of cefoxitin-resistant Escherichia coli as determined by RT-PCR. J Antimicrob Chemother 55:768–772 [View Article][PubMed]
TrépanierS., KnoxJ. R., ClairouxN., SanschagrinF., LevesqueR. C., HuletskyA.1999; Structure-function studies of Ser-289 in the class C β-lactamase from Enterobacter cloacae P99. Antimicrob Agents Chemother 43:543–548[PubMed]
WatanabeR., DoukyuN.2012; Contributions of mutations in acrR and marR genes to organic solvent tolerance in Escherichia coli.. AMB Express 2:58 [View Article][PubMed]
WebberM. A., PiddockL. J. V.2001; Absence of mutations in marRAB or soxRS in acrB-overexpressing fluoroquinolone-resistant clinical and veterinary isolates of Escherichia coli.. Antimicrob Agents Chemother 45:1550–1552 [View Article][PubMed]
WeiY., LeeJ. M., SmulskiD. R., LaRossaR. A.2001a; Global impact of sdiA amplification revealed by comprehensive gene expression profiling of Escherichia coli.. J Bacteriol 183:2265–2272 [View Article][PubMed]
WeiY., VollmerA. C., LaRossaR. A.2001b; In vivo titration of mitomycin C action by four Escherichia coli genomic regions on multicopy plasmids. J Bacteriol 183:2259–2264 [View Article][PubMed]
WhiteD. G., GoldmanJ. D., DempleB., LevyS. B.1997; Role of the acrAB locus in organic solvent tolerance mediated by expression of marA, soxS, or robA in Escherichia coli.. J Bacteriol 179:6122–6126[PubMed]
WisselM. C., WeissD. S.2004; Genetic analysis of the cell division protein FtsI (PBP3): amino acid substitutions that impair septal localization of FtsI and recruitment of FtsN. J Bacteriol 186:490–502 [View Article][PubMed]
YangS., ClaytonS. R., ZechiedrichE. L.2003; Relative contributions of the AcrAB, MdfA and NorE efflux pumps to quinolone resistance in Escherichia coli.. J Antimicrob Chemother 51:545–556 [View Article][PubMed]
YuW., BingL., ZhenhuaL.2009; AmpC promoter and attenuator mutations affect function of three Escherichia coli strains. Curr Microbiol 59:244–247 [View Article][PubMed]
ZhengJ., CuiS., MengJ.2008; Effect of transcriptional activators RamA and SoxS on expression of multidrug efflux pumps AcrAB and AcrEF in fluoroquinolone-resistant Salmonella Typhimurium. J Antimicrob Chemother 63:95–102 [View Article][PubMed]